Literature DB >> 15243388

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

Gilles Bommelaer1, Thierry Poynard, Claude Le Pen, Anne-Françoise Gaudin, Frédérique Maurel, Gaël Priol, Michel Amouretti, Jacques Frexinos, Philippe Ruszniewski, Abdelkader El Hasnaoui.   

Abstract

OBJECTIVES: The main objectives of this study were to assess whether the use of different definitions of irritable bowel syndrome (IBS) could influence measurements of its prevalence and characterize the patient population fulfilling these different diagnostic criteria.
METHOD: A telephone survey was carried out by contacting 8,221 subjects aged >or=18 Years representative of the French population. A "screening" questionnaire based on three algorithms of IBS classification (Manning, with or without a notion of a minimal duration of symptoms, Rome I and Rome II) was used by specialised inquirers.
RESULTS: Twenty three percent of the subjects interviewed stated that they had suffered from abdominal pain during the previous 12 Months. The prevalence of IBS considerably varied, depending on the diagnostic criteria used: 12% based on Manning criteria without reference to the duration of symptoms; 2.5% if the notion of duration of symptoms was added to the Manning criteria, and 2.1% and 1.1% based on the Rome I and Rome II criteria, respectively (the latter including the same notion of duration). In total, 212 subjects (2.6%) met at least one of the criteria including a minimal duration of symptoms, with a predominance for women (sex-ratio close to 2).
CONCLUSION: The prevalence of IBS is strongly dependent on the classification algorithm employed. The requirement of a minimum duration of symptoms eliminates IBS in a large number of subjects complaining of abdominal disorders. Once these methodological variations were taken into account, the prevalence of IBS in France was found to be comparable to that published in international literature.

Entities:  

Mesh:

Year:  2004        PMID: 15243388     DOI: 10.1016/s0399-8320(04)95011-7

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  18 in total

1.  Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS.

Authors:  David Law; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

2.  Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran.

Authors:  Delnaz Roshandel; Mohammadreza Rezailashkajani; Sepideh Shafaee; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2006-03-25       Impact factor: 2.571

3.  Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.

Authors:  Mark Pimentel; Walter Morales; Kathleen Chua; Gillian Barlow; Stacy Weitsman; Gene Kim; Meridythe M Amichai; Venkata Pokkunuri; Emily Rook; Ruchi Mathur; Zachary Marsh
Journal:  Dig Dis Sci       Date:  2011-05-11       Impact factor: 3.199

4.  Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study.

Authors:  O Chassany; B Bonaz; S Bruley DES Varannes; L Bueno; G Cargill; B Coffin; P Ducrotté; V Grangé
Journal:  Aliment Pharmacol Ther       Date:  2007-05-01       Impact factor: 8.171

5.  Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS.

Authors:  Walter Morales; Mark Pimentel; Laura Hwang; David Kunkel; Venkata Pokkunuri; Benjamin Basseri; Kimberly Low; Hanlin Wang; Jeffrey L Conklin; Christopher Chang
Journal:  Dig Dis Sci       Date:  2011-03-16       Impact factor: 3.199

6.  Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?

Authors:  Shunji Ishihara; Monowar Aziz; Naoki Oshima; Yoshiyuki Mishima; Hiroshi Imaoka; Ichiro Moriyama; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2009-01-06

7.  Evaluating breath methane as a diagnostic test for constipation-predominant IBS.

Authors:  Laura Hwang; Kimberly Low; Reza Khoshini; Gil Melmed; Ara Sahakian; Marc Makhani; Venkata Pokkunuri; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

8.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

9.  Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply.

Authors:  Dong Won Park; Oh Young Lee
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

10.  Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome.

Authors:  Ruchi Mathur; Ara Ko; Laura J Hwang; Kimberly Low; Ricardo Azziz; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2009-08-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.